Supramolecular Diagnostic Tool: A Freshly Approved HPBCD-Enabled Radioactive Drug Formulation
On September 27, 2024 GE HealthCare announced that the U.S. Food and Drug Administration (FDA) has granted approval of Flyrcado™
A forum for researchers, students and applicants in the field of cyclodextrin technology
On September 27, 2024 GE HealthCare announced that the U.S. Food and Drug Administration (FDA) has granted approval of Flyrcado™